期刊
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 158A, 期 4, 页码 720-725出版社
WILEY
DOI: 10.1002/ajmg.a.35214
关键词
congenital heart disease; multiplex ligation-dependent probe amplification; MLPA; copy number variants; CNVs
资金
- SAFE Network of Excellence (EC) [LSHB-CT-2004-5053243]
- Danish Heart Foundation
- Novo Nordisk Foundation
- SAFE Network of Excellence (EC) under European Union [LSHB-CT-2004-5053243]
Recurrent copy number variants (CNVs) are found in a significant proportion of patients with congenital heart disease (CHD) and some of these CNVs are associated with other developmental defects. In some syndromic patients, CHD may be the first presenting symptom, thus screening of patients with CHD for CNVs in specific genomic regions may lead to early diagnosis and awareness of extracardiac symptoms. We designed a multiplex ligation-dependent probe amplification (MLPA) assay specifically for screening of CHD patients. The MLPA assay allows for simultaneous analysis of CNVs in 25 genomic regions previously associated with CHD. We screened blood samples from 402 CHD patients and identified 14 rare CNVs in 13 (3.2%) patients. Five CNVs were de novo and six where inherited from a healthy parent. The MLPA screen led to early syndrome diagnosis in two of these patients. We conclude that the MLPA assay detects clinically relevant CNVs and suggest that it could be used within pediatric cardiology as a first tier screen to detect clinically relevant CNVs and identify syndromic patients at an early stage. (C) 2012 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据